Free Trial

Surgery Partners (SGRY) Stock Price, News & Analysis

Surgery Partners logo
$21.54 -0.10 (-0.46%)
As of 02:45 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Surgery Partners Stock (NASDAQ:SGRY)

Advanced

Key Stats

Today's Range
$21.38
$21.73
50-Day Range
$21.01
$23.84
52-Week Range
$18.87
$33.37
Volume
1.31 million shs
Average Volume
1.40 million shs
Market Capitalization
$2.76 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$32.88
Consensus Rating
Moderate Buy

Company Overview

Surgery Partners Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
61st Percentile Overall Score

SGRY MarketRank™: 

Surgery Partners scored higher than 61% of companies evaluated by MarketBeat, and ranked 447th out of 951 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Surgery Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings.

  • Upside Potential

    Surgery Partners has a consensus price target of $32.88, representing about 52.1% upside from its current price of $21.61.

  • Amount of Analyst Coverage

    Surgery Partners has only been the subject of 2 research reports in the past 90 days.

  • Read more about Surgery Partners' stock forecast and price target.
  • Earnings Growth

    Earnings for Surgery Partners are expected to grow by 20.90% in the coming year, from $0.67 to $0.81 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Surgery Partners is -15.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Surgery Partners is -15.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Surgery Partners has a P/B Ratio of 0.86. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Surgery Partners' valuation and earnings.
  • Percentage of Shares Shorted

    17.40% of the float of Surgery Partners has been sold short.
  • Short Interest Ratio / Days to Cover

    Surgery Partners has a short interest ratio ("days to cover") of 8.4.
  • Change versus previous month

    Short interest in Surgery Partners has recently increased by 4.18%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Surgery Partners does not currently pay a dividend.

  • Dividend Growth

    Surgery Partners does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    17.40% of the float of Surgery Partners has been sold short.
  • Short Interest Ratio / Days to Cover

    Surgery Partners has a short interest ratio ("days to cover") of 8.4.
  • Change versus previous month

    Short interest in Surgery Partners has recently increased by 4.18%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Surgery Partners has a news sentiment score of 1.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Surgery Partners this week, compared to 5 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Surgery Partners insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $665,150.00 in company stock.

  • Percentage Held by Insiders

    Only 2.70% of the stock of Surgery Partners is held by insiders.

  • Read more about Surgery Partners' insider trading history.
Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SGRY Stock News Headlines

Is Nvidia about to Trigger Another 150X Opportunity?
Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics processing units. Legendary investor Louis Navellier believes this new invention could be even more revolutionary and mint a new wave of millionaires.tc pixel
Surgery Partners: Deleveraging Needs To Be The Priority
See More Headlines

SGRY Stock Analysis - Frequently Asked Questions

Surgery Partners' stock was trading at $21.17 at the beginning of the year. Since then, SGRY stock has increased by 2.1% and is now trading at $21.6110.

Surgery Partners, Inc. (NASDAQ:SGRY) posted its earnings results on Tuesday, August, 5th. The company reported $0.17 EPS for the quarter, topping analysts' consensus estimates of $0.16 by $0.01. The business's revenue for the quarter was up 8.4% on a year-over-year basis.
Read the conference call transcript
.

Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Surgery Partners investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Palo Alto Networks (PANW), ServiceNow (NOW) and Adobe (ADBE).

Company Calendar

Last Earnings
8/05/2025
Today
10/01/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:SGRY
CIK
1638833
Employees
15,000
Year Founded
2004

Price Target and Rating

High Price Target
$43.00
Low Price Target
$24.00
Potential Upside/Downside
+51.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
9 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.43)
Trailing P/E Ratio
N/A
Forward P/E Ratio
32.30
P/E Growth
N/A
Net Income
-$168.10 million
Net Margins
-5.57%
Pretax Margin
3.97%
Return on Equity
2.51%
Return on Assets
1.01%

Debt

Debt-to-Equity Ratio
1.10
Current Ratio
1.93
Quick Ratio
1.78

Sales & Book Value

Annual Sales
$3.11 billion
Price / Sales
0.89
Cash Flow
$1.85 per share
Price / Cash Flow
11.70
Book Value
$25.15 per share
Price / Book
0.86

Miscellaneous

Outstanding Shares
128,210,000
Free Float
124,747,000
Market Cap
$2.77 billion
Optionable
Optionable
Beta
1.76

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:SGRY) was last updated on 10/1/2025 by MarketBeat.com Staff
From Our Partners